Animal model for protease activity and liver damage

Details for Australian Patent Application No. 2004272114 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kalkeri, Gururaj; Kwong, Ann

Agent Wrays

Pub. Number AU-B-2004272114

PCT Pub. Number WO2005/025517

Priority 60/526,410 01.12.03 US; 60/514,739 27.10.03 US; 60/588,909 16.07.04 US; 60/502,742 12.09.03 US

Filing date 13 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 4 November 2010

International Classifications

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 15/06 (2006.01) Mutation or genetic engineering - Animal cells

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025517 Priority application(s): WO2005/025517

4 November 2010 Application Accepted

  Published as AU-B-2004272114

3 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272121-Method for preparing cucurbiturils

2004272112-Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates